Novocure (NASDAQ: NVCR) reported Q2 EPS of ($0.14), $0.15 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $133.5 million versus the consensus estimate of $141.89 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.